Skip to content

AdaptiveStim Objectifying Subjective Pain Questionnaires

AdaptiveStim Objectifying Subjective Pain Questionnaires

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02974101
Acronym
EMINENT
Enrollment
39
Registered
2016-11-28
Start date
2016-11-30
Completion date
2017-06-30
Last updated
2017-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Failed Back Surgery Syndrome

Keywords

Spinal cord stimulation, AdaptiveStim

Brief summary

This is a prospective, multi-center, correlation study in which the investigators aim to explore the relationship between subjective pain questionnaires and the AdaptiveStim accelerometer output.

Detailed description

The aim of this research is to gather the necessary information relating to the patient his subjective self-report and the more objective information from the implanted IPG (RestoreSensor). Such subjective information can be gathered from the AdaptivStim output. The main focus of this study is to explore the relationship between the subjective reporting of functional disability with the ODI, sleep quality with the Actiwatch and PSQI, pain intensity with the NRS-diary and the objective measurement of functional positions with the AdaptiveStim in patients receiving high density spinal cord stimulation.

Interventions

OTHERregistration of AdaptiveStim

Sponsors

Medtronic
CollaboratorINDUSTRY
Moens Maarten
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* FBSS patients treated with SCS (IPG = RestoreSensor) who achieved a steady state (steady state is considered when the parameters didn't changed for at least one month) * Age \> 18 years

Exclusion criteria

* Patients with Parkinson's disease * Patients immobilised due to limb/pelvis/costal fractures * Stroke patients with MRS\>3

Design outcomes

Primary

MeasureTime frameDescription
AdaptiveStim outputThe change between baseline (T1) and the second assessment 7 days later (T1+7days)The Implantable Pulse Generator contains a processor and accelerometer to record objective information about 7 functional positions.
DisabilityDisability will be measured at the second assessment namely 7 days after the first assessmentDisability will be measured using the Oswestry Disability Index (ODI) questionnaire

Secondary

MeasureTime frameDescription
Numeric Rating Scale (NRS) pain diaryThree times every day (morning, afternoon and evening), during 7 days (from baseline assessment (T1) to second assessment (T1+7days))
Objective sleep quality will be measured using the Actiwatch spectrum plus (Respironics).Three times every day (morning, afternoon and evening), during 7 days (from baseline assessment (T1) to second assessment (T1+7days))This compact and lightweight electronic device similar in size to a wristwatch is worn on the non-dominant hand, and measures and records sleep quality
Subjective sleep qualityDisability will be measured at the second assessment namely 7 days after the first assessmentSubjective sleep quality will be assessed with the Pittsburgh Sleep Quality Index (PSQI).

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026